Digavalli V. Sivarao

Author

Bristol-Myers Squibb (United States)ORCID

Also Known As

D. V. Sivarao, D.V Sivarao, D.V. Sivarao, Digavalli V Sivarao, Digavalli V. Sivarao

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University Medical Center New Orleans Harvard University Bristol-Myers Squibb (Germany)

About

Digavalli V. Sivarao is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	808
2	Health Sciences	4	4	237
3	Natural Sciences	3	3	106
4	Social Sciences	3	3	105
5	Anesthesia	1	1	14

Digavalli V. Sivarao

Publications

931

Citations

H-Index

Page 1

	Year	Citations
Lower Esophageal Sphincter Is Achalasic in nNOS−/− and Hypotensive in W/Wv Mutant Mice Digavalli V. Sivarao, Hiroshi Mashimo, Hemant S. Thatte, Gastroenterology EsophagusPhysiologyGastroenterologyPathologyW/wv Mutant Mice	2001	164
40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors Digavalli V. Sivarao, Ping Chen, Arun Senapati, Neuropsychopharmacology Auditory ProcessingNeurophysiologyMedicinePhysiologyNeurophysiological Biomarkers	2016	129
Pyloric Sphincter Dysfunction in nNOS−/− and W/Wv Mutant Mice: Animal Models of Gastroparesis and Duodenogastric Reflux Digavalli V. Sivarao, Hiroshi Mashimo, Raj K. Goyal Gastroenterology Duodenogastric RefluxPyloric Sphincter DysfunctionMedicineFood DigestionPhysiology	2008	72
MK-801 disrupts and nicotine augments 40 Hz auditory steady state responses in the auditory cortex of the urethane-anesthetized rat Digavalli V. Sivarao, Mikhail Y. Frenkel, Ping Chen, Neuropharmacology Neurobiological MechanismNeurophysiologyMedicineNicotineAuditory Cortex	2013	58
Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition: Identification of (<i>S</i>)<i>-N</i>-[1-(4-Fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an Orally Bioavailable KCNQ2 Opener Devoid of CYP3A4 Metabolism-Dependent Inhibition Yong‐Jin Wu, Carl D. Davis, Steven I. Dworetzky, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceBiochemistryMedicine	2003	58
( <i>S</i> )- <i>N</i> -[1-(3-Morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: An Orally Bioavailable KCNQ2 Opener with Significant Activity in a Cortical Spreading Depression Model of Migraine Yong‐Jin Wu, Christopher G. Boissard, Corinne Greco, Journal of Medicinal Chemistry	2003	54
NR2B Antagonist CP-101,606 Abolishes Pitch-Mediated Deviance Detection in Awake Rats Digavalli V. Sivarao, Ping Chen, Yili Yang, Frontiers in Psychiatry NeuropsychologyNeurotransmitterPsychopharmacologySocial SciencesCognitive Neuroscience	2014	53
2-Butoxyethanol autoprotection is due to resiliance of newly formed erythrocytes to hemolysis Digavalli V. Sivarao, Harihara M. Mehendale Archives of Toxicology InflammationHeme DegradationImmunologyHematologyToxicology	1995	46
Vagally-regulated gastric motor activity: evidence for kainate and NMDA receptor mediation Digavalli V. Sivarao, Zbigniew K. Krowicki, T. Abrahams, European Journal of Pharmacology Physiological ResearchHealth SciencesNeurophysiologyPhysiologyNeuropharmacology	1999	36
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia Linda J. Bristow, Amy Easton, Yu-Wen Li, PLoS ONE Cognitive SymptomsPsychopharmacologyPharmacotherapyBms-933043 Treatment IExperimental Pharmacology	2016	30

Page 1